Skip to content
Study details
Enrolling now

Effectiveness of Magnesium with Prochlorperazine for Migraines

Wake Forest University Health Sciences
NCT IDNCT06904287ClinicalTrials.gov data as of Apr 2026
Phase

Phase 3

Target enrollment

100

Study length

about 1.5 years

Ages

18+

Locations

1 site in IL

About this study

This trial is testing if adding magnesium to prochlorperazine helps lessen migraine pain. It involves adults and will last approximately 546 days. Participants are expected to be enrolled in about 100 people.

Based on ClinicalTrials.gov records.

What participants do

  • 1.Take Magnesium
  • 2.Take Placebo
PhasePhase 3
DrugMagnesium
Primary goalMean change in pain - baseline to 30 minutes

Participation effort

Estimated from trial records. Details can vary by site.

Time + visits
Low7%
Logistics
Moderate50%

Logistics difficulty varies by site location and availability.

Trial highlights

Treatment details

Auto-extracted from trial records to preview treatments and outcomes.

Drug classes

Therapeutic Nutrients/Minerals/Electrolytes (Acid-Base Activity)

Endpoints

Primary: Mean change in pain - baseline to 30 minutes

Secondary: Emergency Department length of stay, Mean change in pain - baseline to 45 minutes and baseline to 60 minutes, Number of adverse events

Body systems

Neurology